Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Muzaffer, Metintas"'
Autor:
Hakan Akgun, Selma Metintas, Guntulu Ak, Secil Demirkol Canlı, Murat Isbilen, Ali O. Gure, Muzaffer Metintas
Publikováno v:
Archives of Medical Science, Vol 19, Iss 2, Pp 355-364 (2021)
Introduction The prognosis of malignant pleural mesothelioma (MPM) is poor, with a limited survival time. In this study, we aimed to examine expression levels of genes selected from relevant literature and to utilize in silico methods to determine ge
Externí odkaz:
https://doaj.org/article/4b80ce20d2e1427e8be0682fcd12f6a7
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Background: Radiation pneumonitis (RP) is a dose-limiting toxicity in lung cancer radiotherapy (RT). As risk factors in the development of RP, patient and tumor characteristics, dosimetric parameters, and treatment features are intertwined, and it is
Externí odkaz:
https://doaj.org/article/e66da3378334489e8f355d45160edcde
Publikováno v:
Journal of Environmental Pathology, Toxicology and Oncology. 42:49-57
Lung cancer is the most common type of cancer in the world and about 1 million people die from lung cancer every year in the world. Inflammation is an important factor in the onset, progression and metastasis of lung cancer. The most important regula
Autor:
Flavia Novelli, Michele Carbone, Giovanni Gaudino, Ian Pagano, Muzaffer Metintas, Sandra Pastorino, Betsy Morrow, Haining Yang, Mitsuru Emi, Masaki Nasu, Guntulu Ak, Joelle S. Suarez, Lorenzo Carparelli, Keisuke Goto, Yoshie Yoshikawa, Raffit Hassan, Michael Minaai, Yasutaka Takinishi, Joseph J. Grzymski, Ronghui Xu, Muhittin Akarsu, Mika Tanji, Jin-Hee Kim, Joanna L. Groden, Harvey I. Pass, Angela Bononi, Angelica Ferro
Publikováno v:
Proceedings of the National Academy of Sciences. 117:33466-33473
Rare biallelic BLM gene mutations cause Bloom syndrome. Whether BLM heterozygous germline mutations (BLM+/−) cause human cancer remains unclear. We sequenced the germline DNA of 155 mesothelioma patients (33 familial and 122 sporadic). We found 2 d
Autor:
Eskisehir Osmangazi Universitesi Tip Fakultesi, Gogus Hastaliklari Anabilim Dali, Eskisehir, Muzaffer Metintas
Publikováno v:
Güncel Göğüs Hastalıkları Serisi. 7:114-131
Publikováno v:
International journal of clinical oncology. 27(7)
To investigate the changes in epidemiological and survival characteristics of malignant mesothelioma (MM) cases diagnosed in a 30-year period between 1990 and 2019.Data were analyzed considering three time periods (1990-1999, 2000-2009, 2010-2019) wh
Autor:
Stefano Landi, Luciano Mutti, Paolo Aretini, Romano Danesi, Alfonso Cristaudo, Chiara Maria Mazzanti, Gabriele Moretti, Marco Lucchi, Guntulu Ak, Federica Gemignani, Muzaffer Metintas, Francesca Lessi, Alessandra Bonotti, Cecilia Lando, Andrea Bottari, Alessandro Apollo, Marzia Del Re, Rudy Foddis, Rosa Filiberti
Publikováno v:
Cancers
Volume 13
Issue 10
Cancers, Vol 13, Iss 2445, p 2445 (2021)
Volume 13
Issue 10
Cancers, Vol 13, Iss 2445, p 2445 (2021)
Background: Malignant pleural mesothelioma (MPM) is a fatal tumor with a poor prognosis. The recent developments of liquid biopsies could provide novel diagnostic and prognostic tools in oncology. However, there is limited information about the feasi
Publikováno v:
Turkish journal of medical sciences. 52(1)
BACKGROUND/AIM Fine-needle non-aspiration cytology (FNNAC) is an easy-to-apply, minimally invasive diagnostic method that contributes to the diagnosis and staging of lung cancer. FNNAC can be performed from peripheral lymph nodes as well as in periph
Autor:
Atila Gurgen, Selma Metintaş, Ragip Ozkan, Güntülü Ak, Muzaffer Metintas, Furkan Erturk Urfali
Publikováno v:
Journal of cancer research and therapeutics. 17(1)
Malignant pleural mesothelioma (MPM) is a pleural tumor with high mortality rate and short-term survival expectancy after diagnosis. Assessment of the response to chemotherapy, which is the first choice in treatment of MPM, is important for the trans
Autor:
Gaye Ulubay, Akin Ozturk, Ozge Aydin Guclu, Murat Kavas, Ülkü Yılmaz, Pinar Celik, Mehmet Karadag, Nilgün Yılmaz Demirci, Berna Komurcuoglu, Adil Zamani, Ufuk Yilmaz, Tuba Inal Cengiz, Irem Serifoglu, Pınar Akın Kabalak, Dursun Alizoroglu, Senay Yilmaz, Selma Metintaş, Suna Kavurgacı, Sedat Altin, Muzaffer Metintas, Gulsah Gunluoglu, Erdal In, Meftun Unsal, Tuğçe Şahin Özdemirel, Özgür Batum, Asude Aksoy, Yurdanur Erdogan, Berna Akıncı Özyürek, Derya Kızılgöz, Guntulu Ak
Publikováno v:
Journal of occupational and environmental medicine. 63(3)
Objective: The aim of this study is to investigate the effect of asbestos exposure on cancer-driver mutations. Methods: Between January 2014 and September 2018, epidermal growth factor receptor (EGFR), anaplastic lymphoma receptor tyrosine kinase (AL